Drug Trial Radar · NCT04449588
Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS
Last checked: Nov 19, 2026Latest source record: May 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
369
Actual
Start
Jul 23, 2020
Primary completion
Mar 26, 2024
Study completion Mar 26, 2024
Sponsor
- Lead sponsor
- Staidson (Beijing) Biopharmaceuticals Co., LtdIndustry
- Sponsor type
- Industry
- Collaborators
- Beijing Defengrui Biotechnology Co. Ltd
- First posted
- Jun 29, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This multi-center, open, randomized study will evaluate the efficacy and safety of BDB-001 injection in severe COVID-19 with severe pneumonia, or acute lung injury/acute respiratory distress syndrome. Patients will be randomized to two treatment arms (Arm A: Conventional treatment + BDB-001; Arm B: Conventional treatment alone).
Conditions
- COVID-19 Pneumonia
Interventions
BDB-001 InjectionDrug
BDB-001 Injection+Conventional treatment
Conventional treatmentOther
Conventional treatment only. Local guidelines should be integrated to choose the best supportive care.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to recovery of peripheral capillary oxygen saturation (SpO2) from baselineTime frame: Baseline to Day 28
Locations
12 sites in 5 countries. Site status is shown where the registry gives one.
Asgar Ali Hospital
Dhaka, Bangladesh
Bangladesh Specialized Hospital
Dhaka, Bangladesh
Southwest Hospital Chongqing
Chongqing, Chongqing Municipality, China
Noble Hospital Pvt Ltd
Nagpur, India
Government Medical College and Hospital
Pune, India
RSUD Pasar Minggu(Pasar Minggu General Hospital)
Jakarta, Indonesia
RSUP Persahabatan(Persahabatan General Hospital)
Jakarta, Indonesia
RSUD Cengkareng(Cengkareng General Hospital)
Jakarta, Jakrata, Indonesia
Hospital Universitario 12 De Octubre
Madrid, Spain
Hospital Universitario Clínico San Carlos
Madrid, Spain
Hospital Universitario de la Princesa
Madrid, Spain
Hospital Universitario Fundación Díaz
Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.